Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$19.73 +0.37 (+1.91%)
As of: Oct 20, 2026 · 10:18 AM EDT

Amneal Pharmaceuticals (AMRX) Current Debt (2020 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) reported Current Debt of -$75 million for FY2018, compared with $50 million in FY2017.

Analysis

Amneal Pharmaceuticals (AMRX) Current Debt (2020 - 2026) Analysis & Trends

  • According to Business Quant data, Current Debt came in at $50 million in FY2017 and -$25 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,158.69 Bn 1,127.28 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 622.73 Bn 541.26 Bn 17.26 Bn -5.75 Bn
3 AbbVie 509.26 Bn 482.37 Bn 12.70 Bn -
4 Merck 365.63 Bn 320.01 Bn 12.21 Bn -
5 Novartis Ag 295.70 Bn 259.69 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 260.09 Bn 233.78 Bn 12.86 Bn -
7 Amgen 234.27 Bn 189.67 Bn 7.24 Bn -
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn -
9 Pfizer 170.77 Bn 117.42 Bn 10.94 Bn 64.00 Mn
10 Amneal Pharmaceuticals 6.29 Bn 5.48 Bn 334.51 Mn 100.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.00 Mn
Mar 31, 2025 218.00 Mn
Mar 31, 2024 48.00 Mn
Dec 31, 2023 109.00 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 20.00 Mn
Mar 31, 2023 80.00 Mn
Jun 30, 2022 85.00 Mn
Mar 31, 2020 300.00 Mn
API Access

Amneal Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=AMRX&period=max&api_key=YOUR_API_KEY